Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

David Ridley

Senior Editor – Europe

During his time at OTC bulletin, David focused mainly on the European OTC market, especially German-speaking countries: Germany, Austria and Switzerland). David is interested in European OTC, herbal/homeopathic, food supplement and self-care medical device regulation, and prescription-to-OTC switches in particular. Before working for OTC bulletin, David was a Lecturer in English and Journalism, and alongside his job David moonlights as a musician in a heavy metal band.
Set Alert for Articles By David Ridley

Latest From David Ridley

Germany's OTC Market in 2019: Stagnation Overall, Online Growth Continues

A weak cough and cold season in Germany last winter held back OTC sales growth in 2019, according to IQVIA, while the country's online pharmacy channel continued to expand. 
Health OTC Drugs

DDD Bringing New Life To UK’s Baby-Care Category

DDD Ltd's global marketing director Katy Holder tells HBW Insight how the company is looking to carve out a niche in the UK's baby-care market with naturally derived ingredients and family-friendly product portfolios. 
Health OTC Drugs

HRA Educating Young Britons About Emergency Contraception

Over half of the UK's Generation Z have no idea how emergency contraption works. HRA Pharma is looking to change this with its Fact Not Fiction PR campaign for EllaOne.
Health OTC Drugs

Triptan Switches Offer Hope For Australia’s OTC Market

Switch expert Natalie Gauld says recent triptan switch recommendations signal a turnaround for Australia's OTC market.
Health Prescription To Otc Switch

Perrigo Launches OTC Viagra Rival In UK

Perrigo is launching in the UK an OTC sildenafil generic to compete with Pfizer's erectile dysfunction drug Viagra Connect.

Launches Generic Drugs

Perrigo To Launch UK Private-Label Viagra Connect Competitor

Perrigo is launching in the UK an OTC sildenafil generic to compete with Pfizer's erectile dysfunction drug Viagra Connect. 
Health OTC Drugs
See All
UsernamePublicRestriction

Register